Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Tumor-Infiltrating T-Cells as a Biomarker for Advanced Epithelial Ovarian Cancer

NCT01000259 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT01000259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01000259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Tumor-Infiltrating T-Cells as a Biomarker for Advanced Epithelial Ovarian Cancer
Lead sponsor
Gynecologic Oncology Group
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2004
Completion date
Not reported
Enrollment
174 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iiia ovarian cancer, stage iiib ovarian cancer, stage iiic ovarian cancer, stage iv ovarian cancer